Illinois · Nonprofit
SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM
SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM (Illinois) receives grants from 1 organization whose IRS filings report $5 to it, the largest being AMAZONSMILE FOUNDATION ($5). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2025
- $685k
- Funders on record
- 1
- Grants received
- $5
- Net assets
- $1.7M
What Society of Urologic Oncology Clinical Trials Consortium does
Mission
The society is a national alliance of leading academic and community based uro-oncologists committed to the following - to further urology research and pharmaceutical trials, - to offer & provide for the best possible approach to disease education and management providing for better patient outcomes, - to provide education for the profession to further the learnings conducted through the profession, - and to allow clinicians to be aware of existing research, which advances further clinical education and hypotheses.
As stated on its FY2025 Form 990.
Program
The consortium assists doctors and hospitals conducting clinical trials with expedited concept and protocol review, standardized protocol and contract language, and centralized data management to help test needed therapies more rapidly the suo-ctc directs revenues generated from sponsor agreements to fund the collective academic, research, corporate and administrative objectives of the consortium in return the suo-ctc offers a variety of value-added services which are of shared benefit to the uro-oncology community, pharmaceutical industry both locally and abroad.
$253,237 spent$684,500 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $253,237.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $561k to $1.0M (+82%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
0% of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM’s revenue is contributions — more earned-revenue than three-quarters of its peers (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
Grant support over time, funder by funder — shade shows the grant size each year.
1 of 1 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 100% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Too little is directly attributable to place on a map.
Funder states come from each funder’s own filing. $5 arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM runs a healthier operating margin than three-quarters of the 7,883 health nonprofits its size.
this organization peer median middle 50% of peers· 7,883 health nonprofits $100k–$1M, FY2025
Organizations like SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Illinois
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
81% of spending goes to programs.
Governance
Public support
100%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM?
- SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM (Illinois) receives grants from 1 organization whose IRS filings report $5 to it, the largest being AMAZONSMILE FOUNDATION ($5). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM have?
- IRS filings report 1 organization giving $5 in grants to SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM.
- Who is the largest funder of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM?
- AMAZONSMILE FOUNDATION is the largest funder on record, with $5 in grants. The full list of funders is on this page.
- How can an organization like SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Illinois. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Society of Urologic Oncology Clinical Trials Consortium →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing